4XC1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Kalvista Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 22.8 EUR 0.18% Market Closed

Market Cap: €503.7m

K	Kalvista Pharmaceuticals Inc SWB:4XC1	US
	Suzuken Co Ltd TSE:9987	JP
E	Edelweiss Financial Services Ltd BSE:532922	IN
B	B.A.G. Films and Media Ltd BSE:532507	IN
	Zoomcar Holdings Inc OTC:ZCAR	US
R	Raiffeisen Bank International AG XETRA:RAW	AT

Profitability Summary

Kalvista Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

94%

Strong 3Y Average Gross Margin

80%

Negative Operating Margin

-228%

Negative 3Y Average Operating Margin

-2 758%

Negative Net Margin

-223%

Negative 3Y Average Net Margin

-2 709%

Negative Free Cash Flow Margin

-170%

Negative 3Y Average Free Cash Flow Margin

-4 442%

Negative ROE

-167%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-367%

ROIC is Increasing

-351% > 920%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.